← FDA Drug Approvals (Drugs@FDA)
DAPSONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2025-04-04
Drug application
- FDA Application #
ANDA218457- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DAPSONE
- Generic name
- DAPSONE
- Active ingredients
- DAPSONE
- Dosage form
- GEL
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- AUROBINDO PHARMA LTD
- Manufacturer
- Aurobindo Pharma Limited
- First approval
- 2025-04-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown